New Year Address of Beroni Group

About
R&D
Core Businesses
Products
- By Beroni China
- By Medicine Plus
Investors
News
Contact
English

Menu

Home>
2018>
December>
29>
2018>
New Year Address of Beroni Group

New Year Address of Beroni Group

admin
2018-12-29
2018

You Might Also Like

Tianjin Beroni Biotechnology Co., Ltd. wins the title of “China Market Credit Enterprise”

2018-05-15

H. E. Yukio Hatoyama, Former Prime Minister of Japan attending The Second Precision Medicine & Medical Care and Aging International Forum

2018-12-21

Beroni Group welcomed Yukio Hatoyama , Former Prime Minister of Japan, to guide work

2018-03-23

Search Article

Arrange by Year

2017 (11)
2018 (25)
2019 (9)

What’s New

Beroni China has achieved the ISO 9001 Certification
Official Trading of Beroni Group Limited on the OTCQX Market
Enhancing environmental awareness, improving product quality, and promoting enterprise image －Beroni Group conducting ISO9001 and ISO14001 training
Beroni Group got the certificate of “Tianjin Key New Product” for its independently innovative product
Statements on “B&R and Building a Community with Shared Future for Mankind Forum”

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the U.S.A with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trail, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

About Beroni
Our History
Board of Directors
Management Team
Vision, Mission, and Values

Core Businesses

Cell Therapy
Anti-Cancer Drugs
Infectious Diseases
E-Commerce

Products

By Beroni China
By Beroni Japan
By Beroni USA
By Medicine Plus

website by chase e-Design

Close Menu